No Data
No Data
BofA Securities Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $36
$RXST Stock Is up 8% Today. Here's What We See in Our Data.
BofA Sees Bausch + Lomb IOL Recall News as Positive for RxSight
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
BofA Securities Maintains RxSight(RXST.US) With Buy Rating, Cuts Target Price to $36
RxSight Is Maintained at Buy by B of A Securities